Header Logo

Connection

Dusan Stefoski to Drug Eruptions

Back to Details
This is a "connection" page, showing publications Dusan Stefoski has written about Drug Eruptions.
Dusan Stefoski
Connection Strength
0.035
Drug Eruptions
  1. Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study. BMC Neurol. 2016 Jul 26; 16:117.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.